Edward M. Tavel, Jr., M.D.

Dorsal Spinal Cord Stimulation vs Medical Management for the Treatment of Low Back Pain

A Phase 2, Open-label, Pharmacokinetic Study of a Single Intra Articular Administration of an investigational product in Subjects with Mild to Moderate Osteoarthritis of the Knee

A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the Safety, Efficacy, and Immunogenicity of a Non-replicating ChAdOx1 Vector Vaccine for the Prevention of COVID-19

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Monoclonal Antibodies in Preventing SARS-CoV-2 Infection in Household Contacts of Individuals Infected with SARS-CoV-2

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Assess the Efficacy of an investigational product in Relieving Symptoms of Gastroparesis

A Phase 2, Randomized, Double-Blind, Two-Phase, Multicenter Study to Evaluate the Efficacy and Safety of an investigational product for Healing in Patients with Erosive Esophagitis and Maintenance of Healing in Patients with Healed Erosive Esophagitis

A Phase 3 Randomized Multicenter Study to Evaluate the Efficacy and Safety of Dual Therapy versus Triple Therapy in Patients with Helicobacter Pylori Infection

A Phase 3 Study to Support the Radiographic Eligibility Screening Process in Symptomatic Knee Osteoarthritis Subjects

A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of an investigational product in Subjects with Irritable Bowel Syndrome Experiencing Abdominal Pain

A Randomized, Double-blind, Multi-dose, Placebo-controlled Study to Evaluate the Efficacy and Safety of an investigational product in Patients with Pain due to Osteoarthritis of the Knee

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study to Assess the Efficacy and Safety of an investigational product in Subjects with Moderate to Severe Endometriosis-Associated Pain

A Phase 3, Randomized, Placebo-controlled, 12-week Double-blind Study to Assess the Efficacy and Safety of an investigational product in Women Suffering from Moderate to Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause

A Randomized, Placebo-Controlled, Double-Blind Phase 3 Clinical Study to Investigate the Long-Term Safety of an investigational product in Women Suffering From Vasomotor Symptoms (Hot Flashes) Associated with Menopause

A Prospective Phase 3, Randomized, Multi-center, Double-blind Study of the Efficacy, Tolerability, and Safety of an oral investigational product versus Ciprofloxacin for Treatment of Uncomplicated Urinary Tract Infections in Adult Women

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Single Attack Study to Evaluate the Efficacy, Safety, and Tolerability of an oral investigational product in the Acute Treatment of Migraine

A Multicenter, Randomized, Open-label Extension Study to Evaluate Long-term Safety and Tolerability of an oral investigational product in the Acute Treatment of Migraine with or without Aura

Multi-center Retrospective Study Determining the Sustainability of Pain Relief and Psychosocial and Functional Responses when Utilizing a Multiple Waveform Enabled Neurostimulator

A Prospective, Randomized, Double-Blinded, Vehicle- and Placebo-Controlled, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of an investigational product in Subjects with Single-Level, Symptomatic Lumbar Intervertebral Disc Degeneration

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of an investigational product in Patients with Hip Osteoarthritis

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of an investigational product in Patients with Lactose Intolerance

A Phase 2, 52-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of Two Injections of an investigational product in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects

Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Multiple Dosing Regimens for the Prevention of Migraine in Patients with Episodic Migraine

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of an investigational product Administered Orally for 8 Weeks to Patients with Symptomatic Gastroesophageal Reflux Disease Not Completely Responsive to Proton Pump Inhibitors

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of an investigational product in Subjects with Moderate to Severe Crohn’s Disease

A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of an investigational product in the Treatment of Overactive Bladder (OAB) in Adult Female Subjects

A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of an investigational product in Patients with Diabetic Gastroparesis

A 46-week, Double-blind, Placebo-controlled, Phase 3 Study with a 6-week Randomized-withdrawal Period to Evaluate the Safety and Efficacy of an investigational product in Patients with Diabetic Gastroparesis

A 52-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of an investigational product in Patients with Diabetic Gastroparesis

A Phase 1, Open-label Study of the Safety, Tolerability, and Pharmacokinetics of an investigational product Following Single Intradiscal Injection in Subjects with Degenerative Disc Disease

A Phase 2, 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of an investigational product for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis

Open-label Safety Trial of Intravenous Investigational Product in Subjects with Complex Regional Pain Syndrome (CRPS)

A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of an investigational product Compared with Placebo or Active Comparator Twice Daily for 5 Days in Otherwise Healthy Patients with Influenza

A Randomized, Placebo-controlled, Double-blinded, Multicenter Study of the Efficacy and Safety of a Sprinkle Formulation of an investigational product in Adult Subjects with Chronic Idiopathic Constipation

A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered Investigational Product in Patients with Osteoarthritis of the Hip or Knee

A Study of Three Doses of an investigational product Compared to Placebo in the Acute Treatment of Migraine: A Randomized, Double-blind, Placebo-controlled Parallel Group Study

An Open-label, Long-term, Safety Study of an investigational product in the Acute Treatment of Migraine

A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study with a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of an investigational product for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)

Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study Comparing Investigational Doses with Placebo over 52 Weeks in Approximately 500 Patients with Mild Alzheimer’s Disease Dementia

A Randomized Withdrawal, Double-blind, Placebo-controlled Phase 3 Trial to Evaluate the Efficacy and Safety of an investigational product in Patients with Moderate-to-Severe Chronic Low Back Pain

A Phase 3, Multisite, Randomized, Double-blind, Placebo-controlled, 6-month Study to Compare the Efficacy and Safety of Two Doses of an investigational product in Preventing Migraine Headaches in Patients with Episodic Migraine (with or without Aura)

A Phase 3, Multisite, Double-blind, Randomized, Placebo-controlled, 3-month Study to Compare the Efficacy and Safety of Two Doses of an investigational product in Preventing Migraine Headaches in Patients with Chronic Migraine, with Optional 9-month Open-label Extension

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Topically Applied Investigational Product in Patients with Post-herpetic Neuralgia

A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of an Intra-Articular Injection of an investigational product in Adults with Pain Due to Osteoarthritis of the Knee

Long-term, Prospective, Multinational, Parallel-cohort Study Monitoring Safety in Patients with MS Newly Started on an investigational product Once Daily or Treated with Another Approved Disease-Modifying Therapy

A Multicenter, Open-label Study of an investigational product in Patients with Lumbar Disc Herniation

Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an investigational product as Monotherapy in Subjects with Signs and Symptoms of Osteoarthritis of the Hip or Knee

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Single Dose of an investigational product in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of an investigational product as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn’s Disease

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of an investigational product in Patients with Episodic Cluster Headaches

A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of a Single Injection or Combined Injection in Subjects with Chronic Discogenic Lumbar Back Pain Through 12 Months

Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of an investigational product Compared with Adalimumab and Placebo in Patients with Moderate to Severe Ulcerative Colitis Who Are Naïve to TNF Inhibitors

A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of an investigational product for the Treatment of Opioid-induced Constipation in Subjects with Nonmalignant Chronic Pain Receiving Opioid Therapy

A Phase 3 Multi-Center Actual-Use Study on the Safety of an investigational product for the Treatment of Moderate to Severe Acute Pain Associated with Osteoarthritis of the Knee or Hip

A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of an investigational product Administered Orally for 8 Weeks to Adult Outpatients with Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain

An Interventional Phase II/III Randomized, Double-blind Trial Investigating the Efficacy and Safety of Intravenous Investigational Product in Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

A Phase 2, Randomized, Double-Blind, Placebo and Active-Controlled Trial of an investigational product in Patients with Mild to Moderate Osteoarthritis Pain of the Knee

A Phase 3 Multicenter, Randomized, Double-blind, Controlled, Comparative Study of an investigational product in Patients with Lumbar Disc Herniation (Phase III)

A Prospective, Randomized, Multi-Center, Controlled Clinical Trial to Assess the Safety and Efficacy of the Spinal Modulation Neurostimulator System in the Treatment of Chronic Pain

A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi-Center, Efficacy and Safety Clinical Trial of a Topically Applied Gel in Subjects with Moderate to Severe Pain Associated with Osteoarthritis of the Knee

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of an investigational product as Add-on to Preexisting Antihyperglycemic Therapy over 16 Weeks with 36-week Extension in Type 2 Diabetic Subjects with Chronic Kidney Disease Stage 4 or Stage 5 on Dialysis

A Randomized, Prospective, Multicenter, Clinical Study Designed to Demonstrate the Safety and Efficacy of a Neurostimulation System Using Multiple Stimulation Therapy Modalities to Manage Patients with Chronic Intractable Pain

A Phase 3b, Randomized, Double-Blind, Placebo-controlled, Parallel-Treatment Group, Multicenter Efficacy and Safety Study of an investigational product in Subjects with Anal Fissure

Cardiovascular Safety & Renal Microvascular Outcome with an investigational product in Patients with Type 2 Diabetes Mellitus at High Cardiovascular Risk

A Phase 3, Open-Label, Long-Term Study to Evaluate the Safety, Tolerability and Analgesic Efficacy of an investigational product in Subjects with Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Safety and Efficacy of a Single Treatment of an investigational product in Patients with Postherpetic Neuralgia

A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of an investigational product in Patients with Post-Herpetic Neuralgia (PHN)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Long-term Safety and Tolerability of an investigational product for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain

A Randomized, Double-blind, Double-dummy, Placebo-controlled, Active-controlled, Parallel-group, Multicenter Trial to Assess the Analgesic Efficacy and the Management of Opioid-induced Constipation in Opioid-experienced Subjects with Controlled Moderate to Severe Chronic Low Back Pain

A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety of an Extended-Release Capsule in Subjects with Moderate to Severe Chronic Low Back Pain

A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Efficacy Study of an investigational product Versus Placebo in Opioid-Experienced and Opioid-Naïve Subjects with Moderate-to-Severe Chronic Low Back Pain

A Phase 3, Open Label Safety Study of an investigational product in Subjects with Osteoarthritis or Chronic Low Back Pain

A Phase 2 Enriched Enrollment, Randomized-Withdrawal, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy, Tolerability and Safety of an investigational product in Opioid-Naïve Subjects with Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

An Open-Label 52-week Study to Assess the Long-Term Safety of an investigational product in Patients with Opioid-Induced Constipation

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study with an Open-label Run to Assess the Efficacy and Safety of an investigational product in Subjects with Moderate to Severe Chronic Low Back Pain

A Phase 4, Open Label, Study of Safety and Effectiveness of an investigational product in the Treatment of Patients with Post-herpetic Neuralgia in Clinical Practice

A Phase 2b, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of an investigational product in Subjects with Opioid-Induced Constipation

A Multi-Centered Evaluation of Patients with Chronic Pain of the Trunk and/or Limbs using Spinal Cord Stimulation

A Multi-Centered Evaluation of Patients with Chronic Pain of the Trunk and/or Limbs using Paddle Lead(s); Validation of a Multi-Sensor On-Body Monitoring System to Objectively Measure Changes in Physical Function and Sleep in Patients Undergoing Spinal Cord Stimulation

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of an investigational product in Patients with Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of an investigational product in Patients with Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)

An Evaluation of the Burden of Illness among Adults in the United States with Peripheral and Central Neuropathic Pain

A Multi-center, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of an investigational product in Subjects with Opioid-Induced Bowel Dysfunction

A Multicenter, Randomized, Double Blind, Parallel-Group Study of Cardiovascular Safety in Osteoarthritis or Rheumatoid Arthritis Patients With or at High Risk for Cardiovascular Disease Comparing Three Non-Steroidal Medications

A Multi-center, Randomized, Double-blind, Placebo-controlled Study with an Open-label Run-in to Assess the Efficacy, Tolerability, and Safety of an investigational product Compared to Placebo in Opioid-Naïve Subjects with Moderate to Severe Chronic Pain due to Osteoarthritis of the Knee

A Multicenter, Randomized, Double-blind, Sham-controlled, Comparative Study of an investigational product in Subjects with Lumbar Disc Herniation (Phase 3)

A Double-blind, Randomized, Placebo-controlled, Multicenter Study in Subjects with Lumbosacral Radicular Pain Evaluating the Safety and Efficacy of a Single Injection Compared to a Single Placebo IM Injection, Followed by an Open-label Safety Extension

An International Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Multicenter Study to Evaluate the Safety and Efficacy of an investigational product in Patients with Symptoms of Overactive Bladder

An International Phase 3, Randomized, Double-Blind, Active-Controlled Multicenter Extension Study to Evaluate the Long-Term Safety and Efficacy of an investigational product in Patients with Symptoms of Overactive Bladder

A Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy and Tolerability of an investigational Cream for the Treatment of Pain Associated with Post-Herpetic Neuralgia: A Proof of Concept Study

A Phase 3, Multicenter, Observational Long-term Study Evaluating the Safety, Tolerability, and Efficacy of Treatment Previously Injected in the Target Knee Joint of Subjects with Moderately to Severely Symptomatic Osteoarthritis

A Double-blind Placebo-controlled, Randomized Study to Assess the Safety and Efficacy of an investigational Cream for the Treatment of Chronic Pain caused by Osteoarthritis of the Knee: A Proof of Concept Study

A Double-blind, Placebo-controlled, Randomized Study to Assess the Safety and Efficacy of an investigational Cream for the Treatment of Chronic Pain caused by Osteoarthritis of the Knee: A Dose-Ranging Study

A Double-blind, Placebo-controlled, Randomized Dose Ranging Trial to Determine the Safety and Efficacy of Three Dose Levels of an investigational product in Reducing 24-hour Average Pain Intensity Score in Patients with Post-herpetic Neuralgia

A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation